Strategic Merger CTI BioPharma's merger with Sobi AB creates a strong biopharma entity, enhancing the potential to offer innovative medicines to address rare diseases. This expanded portfolio presents opportunities for targeted pharmaceutical sales strategies.
Tech Adoption CTI BioPharma's use of technology platforms like Optimise, SAS, and Microsoft 365 indicates a commitment to efficiency and data-driven decision-making. Leveraging these tech tools can enable tailored sales approaches based on comprehensive analytics.
Financial Stability With revenues between $10M - $50M and recent funding of $50M, CTI BioPharma showcases financial stability in the biotech sector. This financial health provides a favorable environment for potential sales partnerships and collaborations.
Market Positioning Among similar companies, CTI BioPharma competes with established players like Intra-Cellular Therapies and Sage Therapeutics. Understanding CTI's competitive positioning and market presence is crucial for identifying sales opportunities in the industry.
Employee Engagement With a workforce size of 51-200, CTI BioPharma boasts a team that can drive sales growth and operational excellence. Engaging with the company's employees through targeted sales initiatives can foster strong client relationships and drive revenue generation.
702
$100M$1B
614$50M$100M
14$10M
47$10M
51$10MCTI BioPharma uses 8 technology products and services including Optimise, SAS, Microsoft 365, and more. Explore CTI BioPharma's tech stack below.
| CTI BioPharma Email Formats | Percentage |
| FLast@ctibiopharma.com | 94% |
| Last@ctibiopharma.com | 4% |
| First.Last@ctibiopharma.com | 1% |
| FirstLast@ctibiopharma.com | 1% |
| First.Last@sobi.com | 98% |
| First.MiddleLast@sobi.com | 1% |
| FirstMiddle.Last@sobi.com | 1% |
Biotechnology ResearchWashington, United States51-200 Employees
We have merged with Sobi AB creating a biopharma company positioned to provide innovative medicines that transform the lives of people with rare and debilitating diseases. Visit www.sobi.com to continue to learn more about our work. For more information on the acquisition, see our press release at: https://bit.ly/42XKW9M
Company Overview
Funding & FinancialsCTI BioPharma has raised a total of $50M of funding over 8 rounds. Their latest funding round was raised on Aug 25, 2021 in the amount of $50M.
CTI BioPharma's revenue is in the range of $10M$50M
Funding & FinancialsCTI BioPharma has raised a total of $50M of funding over 8 rounds. Their latest funding round was raised on Aug 25, 2021 in the amount of $50M.
CTI BioPharma's revenue is in the range of $10M$50M
1-888-653-2347 
support@leadiq.com